RAAS blockers in hypertension posing a higher risk toward the COVID-19.

Singh, Y Gupta, G Satija, S

Negi, P Chellappan, DK Dua, K

Permalink

Closed Access

	Filename	Description	Size
	dth.13501.pdf	Published version	585.56 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Singh, Y
dc.contributor.author	Gupta, G
dc.contributor.author	Satija, S https://orcid.org/0000-0003-4702-6534
dc.contributor.author	Negi, P
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2020-09-14T05:43:19Z
dc.date.available	2020-04-28
dc.date.available	2020-09-14T05:43:19Z
dc.date.issued	2020-05-02
dc.identifier.citation	Dermatologic therapy, 2020, pp. e13501-e13501
dc.identifier.issn	1396-0296
dc.identifier.issn	1529-8019
dc.identifier.uri	http://hdl.handle.net/10453/142662
dc.format	Print-Electronic
dc.language	eng
dc.publisher	WILEY
dc.relation.ispartof	Dermatologic therapy
dc.relation.isbasedon	10.1111/dth.13501
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences
dc.subject.classification	Dermatology & Venereal Diseases
dc.title	RAAS blockers in hypertension posing a higher risk toward the COVID-19.
dc.type	Journal Article
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2020-09-14T05:43:03Z
pubs.publication-status	Published

Please use this identifier to cite or link to this item: